CDH1 and in situ carcinoma: A multi-institutional study on 678 patients, who underwent RNU, showed that decreased E-cadherin expression in tumor cells was strongly associated with an advanced tumor stage, high tumor grade, lymph node metastases, CIS and multifocality.